Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10137176 Compositions and methods for treating MPSI

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 13, 2014
Date of Patent
November 27, 2018
Patent Application Number
14769596
Patent Citations Received
‌
US Patent 11459558 Methods for using transcription-dependent directed evolution of AAV capsids
‌
US Patent 11890329 AAV9-mediated gene therapy for treating mucopolysaccharidosis type I
0
‌
US Patent 12084653 Methods for using transcription-dependent directed evolution of AAV capsids
0
‌
US Patent 12084654 Methods for using transcription-dependent directed evolution of AAV capsids
0
‌
US Patent 11555059 LDLR variants and their use in compositions for reducing cholesterol levels
‌
US Patent 10792343 Compositions and methods for treating MPSI
‌
US Patent 10973929 Gene therapy for treating mucopolysaccharidosis type I
‌
US Patent 11883470 Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10137176
Patent Primary Examiner
‌
Scott Long

Find more entities like US Patent 10137176 Compositions and methods for treating MPSI

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo